Uncategorized
RH Shares Tank After Q4 Disappoints, Analyst Cuts Price Target By 30%; But There’s A Silver Lining
RH stock dropped after downbeat results and outlook, but analyst maintain Outperform rating on potential for growth in medium-term. Latest Ratings for RH Date Firm Action From To Mar 2022 Wells Fargo Maintains Overweight Jan 2022 Citigroup Maintains Buy Sep 2021 UBS Maintains Neutral View More Analyst Ratings for RH View the Latest Analyst Ratings…
Tesla’s EV Crown At Risk As BYD Closes In With Breakthrough Charging Tech
BYD is poised to surpass Tesla in 2025 with a 15.7% market share, driven by its revolutionary ultra-fast charging tech and strong growth strategy. read more
99% Of Americans Know Bitcoin, But Only 91% Know Dogecoin: Why?
One in five American adults own crypto, with 76% viewing it as having a positive impact on their lives, according to a report conducted by the National Cryptocurrency Association. read more
Trade Strategy For SPY, AAPL, MSFT, NVDA, GOOGL, META, TSLA
Here’s the trading strategy for SPY, AAPL, MSFT, NVDA, GOOGL, META, and TSLA, as Initial and Continuing Jobless Claims set the early tone. read more
GE Vernova’s Gas Turbines Fuel Data Center Project In Pennsylvania: Details
GE Vernova Inc. plans to supply 7 high-efficiency gas turbines capable of running on hydrogen to repurpose a former coal-fired power plant into a natural gas-powered data center campus, providing economic and environmental benefits. read more
FDA Rejects Aldeyra’s Reproxalap For Dry Eye Disease Again, Citing Efficacy Concerns
The FDA rejected Aldeyra’s resubmission for reproxalap, citing efficacy concerns. The company plans another trial and aims to resubmit the NDA by mid-2025. read more